Introduction {#Sec1}
============

Insulin resistance (IR) is a condition in which the reactivity of a target organ to blood insulin is reduced, and is known to be the strongest predictor of type 2 diabetes mellitus occurrence \[[@CR1]\]. IR is considered a core causal factor of hypertension, obesity, coronary artery disease, dyslipidemia, and metabolic syndrome \[[@CR2]\] and is therefore actively studied worldwide.

IR can result from various genetic or acquired causes, including obesity, body fat distribution, reduced physical activity, malnutrition at birth, aging, pregnancy, drug use, chronic hyperglycemia, mitochondrial malfunction, inflammation, and stress \[[@CR3]--[@CR7]\]. In 1985, Matthews et al. first described the homeostasis model assessment for IR (HOMA-IR) as a useful and accurate method for IR quantification \[[@CR8]\]. Since then, several clinicians have researched these data and found HOMA-IR to be a reliable marker of IR \[[@CR9], [@CR10]\].

Recently, researchers have actively attempted to evaluate IR using ratios of various serum lipid concentration levels, such as the total cholesterol/high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C)/HDL-C, and triglyceride (TG)/HDL-C ratios \[[@CR11]--[@CR14]\]. In addition, previous studies have suggested independent associations between IR and the LDL-C/HDL-C \[[@CR13]\], TG/HDL-C, and total cholesterol (TC)/HDL-C ratios \[[@CR11], [@CR12], [@CR14]\].

The serum concentrations of lipids differ according to sex \[[@CR15], [@CR16]\]. However, previous studies have evaluated data without distinguishing male and female subjects. We hypothesized that the strongest predictors of IR might differ between men and women. In the present study, we determined which lipid profile ratio served as the strongest IR predictive index for each sex by studying the associations between lipid profile ratios (e.g., LDL-C/HDL-C, TG/HDL-C, and non-HDL-C/HDL-C) and IR in Korean adults randomly selected from the Korea National Health and Nutrition Examination Survey (KNHANES) 2010.

Methods {#Sec2}
=======

Subjects and data collection {#Sec3}
----------------------------

This study analyzed data from the fifth KNHANES (KNHANES V-1), a cross-sectional and nationally representative survey conducted by the Division of Chronic Disease Surveillance of the Korean Center for Disease Control and Prevention. KNHANES V-1 comprised 4 different surveys designed to evaluate the general health and nutrition status of the Korean population; these included a health interview survey, health behavior survey, health examination survey, and nutrition survey. During KNHANES V-1 2010, 8958 individuals participated in the health interview and health examination surveys. Among them, 1910 people older than 20 years of age who completed physical examinations and 8-h fasting blood tests were selected for the present study (929 men, 981 women). Subjects with missing data were excluded.

Health interviews and physical examinations were conducted at mobile exam centers, and nutrition surveys were conducted during visits to subjects' households. Regarding drinking, the subjects were asked if they had not drunk any alcohol throughout their lives or if they had drunk at least 1 glass per month during the previous 1-year period. Regarding exercise, the subjects were asked to answer whether or not they had performed at least 3 sessions of very intense physical activity per week for 20 min or more per session or whether they had performed at least 5 sessions of moderate physical activity per week for 30 min or more per session.

Physical measurements {#Sec4}
---------------------

Body mass index (BMI) was calculated by dividing the body weight (kg) by the height squared (m^2^). Waist circumference was measured during normal breathing at the center point between the lowest rib and pelvic iliac crest. Blood pressure was measured after the subjects had been seated for a 10-min rest period. Three systolic and diastolic blood pressure readings were recorded with a 5-min interval, and the average value was used for analysis.

Anthropometric and laboratory parameter measurements {#Sec5}
----------------------------------------------------

Plasma glucose and insulin levels after fasting for 8 h or more, as well as total cholesterol, TG, HDL-C, and LDL-C levels, were measured using a Hitachi Automatic Analyzer 7600 (Hitachi, Ltd., Tokyo, Japan). Glycated hemoglobin levels were measured using an HLC-723G7 auto analyzer (Tosoh Corporation, Minato, Japan). Blood samples were centrifuged, refrigerated at the examination site, and transferred in iceboxes to a central laboratory in Seoul on the day of collection.

IR index {#Sec6}
--------

The IR index was calculated using the relatively simple and highly validated homeostasis model assessment (HOMA)-IR \[[@CR8]\] as follows:$$\documentclass[12pt]{minimal}
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Statistical analysis {#Sec7}
--------------------

All analyses were performed separately for each sex. The KNHANES V-1 database sample used in this study was extracted via stratified, clustered, and systematic sampling. We considered strata, clusters, and weights in the statistical analysis. The SURVEYMEANS procedure was used to calculate averages and ratios, and the SURVEYREG and SURVEYFREQ procedures were used in the association analyses of continuous and categorical variables, respectively.

We used the LDL-C/HDL-C, TG/HDL-C, and non-HDL-C (LDL + TG/5)/HDL-C ratios as lipid concentration-ratio-related outcomes in the present study. We divided subjects into 4 groups according to lipid profile ratio quartiles to allow comparisons of HOMA-IR values. In the regression analysis, we adjusted for the confounding factors of age, BMI, waist circumference, and medical history of diabetes mellitus; Log (HOMA-IR) values were used because of the abnormal distribution of HOMA-IR values.

All statistical analyses were performed using SAS version 9.2 (SAS Institute, Cary, NC, USA), and significance was defined as a *p*-value \< 0.05.

This study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the Korea Centers for Disease Control and Prevention institutional review board in Korea (No. 2010-02CON-21-C).

Results {#Sec8}
=======

Baseline characteristics {#Sec9}
------------------------

The mean ages of the male and female subjects were 40.80 (95 % confidence interval (CI), 39.79--41.80) and 41.45 (95 % CI, 40.63--42.26) years, respectively. The mean LDL-C/HDL-C ratios were 2.40 (95 % CI, 2.33--2.46) for men and 2.04 (95 % CI, 1.99--2.09) for women. The mean TG/HDL-C ratios were 3.69 (95 % CI, 3.20--4.18) for men and 2.06 (95 % CI, 1.95--2.17) for women. The mean non-HDL-C/HDL-C ratios were 6.09 (95 % CI, 5.58--6.59) for men and 4.10 (95 % CI, 3.95--4.24) for women. The mean HOMA-IR values were 2.58 (95 % CI, 2.44--2.71) for men and 2.52 (95 % CI, 2.39--2.64) for women. There were significant differences between men and women in terms of smoking status, alcohol consumption, and physical activity. These results suggest that the men and women enrolled in this study experienced different lifestyles, with considerable influences on serum cholesterol levels \[[@CR17], [@CR18]\] (Table [1](#Tab1){ref-type="table"}).Table 1Baseline characteristicsMenWomen*p*-value*N*MeanLower C.I.Upper C.I.*N*MeanLower C.I.Upper C.I.Age (years)92940.8039.7941.8098141.4540.6342.260.2137Height (cm)929171.50170.93172.07981158.40157.95158.85\<0.0001Weight (kg)92971.3070.3872.2298157.7557.0458.47\<0.0001BMI (kg/m^2^)92924.1923.9424.4498123.0722.7523.39\<0.0001Waist Circumference (cm)92284.0883.3884.7797276.8276.0177.63\<0.0001HDL-C (mg/dL)92949.9048.9150.8998156.7755.8557.70\<0.0001LDL-C (mg/dL)929112.93110.56115.29981109.53107.04112.010.0518Total Cholesterol (mg/dL)929187.02184.09189.95981184.53181.56187.500.2129TG (mg/dL)929159.42145.77173.07981105.72100.98110.46\<0.0001LDL-C/HDL-C Ratio9292.402.332.469812.041.992.09\<0.0001TG/HDL-C Ratio9293.693.204.189812.061.952.17\<0.0001Non-HDL-C (mg/dL)929272.35258.69286.00981215.25209.32221.17\<0.0001Non-HDL-C/HDL-C Ratio9296.095.586.599814.103.954.24\<0.0001SBP (mmHg)929118.59117.41119.76981112.61111.49113.74\<0.0001DBP (mmHg)92977.6576.6578.6698171.8771.1172.64\<0.0001Fasting Glucose (mg/dL)92998.6796.33101.0198193.3192.1194.52\<0.0001Fasting Insulin (uIU/mL)92910.4610.0010.9198110.6910.3211.060.4121HOMA-IR9292.582.442.719812.522.392.640.5048N%Lower C.I.Upper C.I.N%Lower C.I.Upper C.I.Hypertension0.3511 No72984.4882.1086.8579685.9283.9687.88 Yes19015.5213.1517.9018014.0812.1216.04Hyperlipidemia0.9149 No83392.5190.4794.5586792.6390.9794.30 Yes857.495.459.531097.375.709.03Diabetes0.1617 No84293.5391.7995.2792095.2293.6996.75 Yes766.474.738.21564.783.256.31Smoking\<0.0001 No49650.6646.7154.6292894.5892.8196.35 Yes42649.3445.3853.30505.423.657.19Alcohol Use\<0.0001 No19220.5917.4823.6958755.8351.5360.12 Yes72279.4176.3182.5238444.1739.8848.47Exercise: high\<0.0001 No73077.4774.0180.9385587.1184.2989.94 Yes19122.5319.0726.0012112.8910.0615.71Exercise: mid0.0798 No81787.1984.4689.9387690.0187.8692.17 Yes10512.8110.0715.541009.997.8312.14*p-*values were calculated using the SURVEYMEANS (for continuous values) and SURVEYFREQ procedures (for categorical values)*BMI* Body mass index, *LDL-C* Low-density lipoprotein cholesterol, *HDL-C* High-density lipoprotein cholesterol, *SBP* Systolic blood pressure, *DBP* Diastolic blood pressure, *HOMA-IR* Homeostasis model assessment of insulin resistance, *C.I.* Confidence interval

Mean comparison of HOMA-IR values among LDL-C/HDL-C, TG/HDL-C, and non-HDL-C/HDL-C ratio quartile groups {#Sec10}
--------------------------------------------------------------------------------------------------------

We divided the subjects into sets of 4 quartile groups according to the LDL-C/HDL-C ratio (first, second, third, and fourth quartile groups:\<1.64000, 1.64000--2.15895, 2.15895--2.78788, and ≥ 2.78788, respectively), TG/HDL-C ratio (first, second, third, and fourth quartile groups:\<1.25581, 1.25581--2.04302, 2.04302--3.50000, and ≥ 3.50000, respectively), and non-HDL-C/HDL-C ratio (first, second, third, and fourth quartile groups:\<3.07042, 3.07042--4.28846, 4.28846--6.31818, and ≥ 6.31818, respectively) (Table [2](#Tab2){ref-type="table"}).Table 2Mean comparison of HOMA-IR values among LDL-C/HDL-C, TG/HDL-C, and non-HDL-C/HDL-C ratio quartile groups(A) Men1st Quartile2nd Quartile3rd Quartile4th Quartile*p*-valueLDL-C/HDL-C^a^*N* = 183*N* = 210*N* = 251*N* = 285MeanLower C.IUpper C.IMeanLower C.IUpper C.IMeanLower C.IUpper C.IMeanLower C.IUpper C.I HOMA-IR2.232.092.372.512.082.942.542.342.742.902.673.14\<0.0001 Log (HOMA-IR)0.720.660.790.780.690.870.830.770.900.950.891.02\<0.0001TG/HDL-C^b^*N* = 137*N* = 200*N* = 257*N* = 335MeanLower C.IUpper C.IMeanLower C.IUpper C.IMeanLower C.IUpper C.IMeanLower C.IUpper C.I HOMA-IR1.991.802.172.292.102.482.462.262.673.132.833.43\<0.0001 Log (HOMA-IR)0.630.560.700.740.680.810.800.730.861.020.971.08\<0.0001Non-HDL-C/HDL-C^c^*N* = 146*N* = 204*N* = 241*N* = 338MeanLower C.IUpper C.IMeanLower C.IUpper C.IMeanLower C.IUpper C.IMeanLower C.IUpper C.I HOMA-IR1.991.822.172.232.072.402.592.382.813.082.773.40\<0.0001 Log (HOMA-IR)0.620.550.690.730.670.790.850.780.911.000.941.07\<0.0001(B) Women1st Quartile2nd Quartile3rd Quartile4th Quartile*p*-valueLDL-C/HDL-C^d^*N* = 294*N* = 268*N* = 228*N* = 191MeanLower C.IUpper C.IMeanLower C.IUpper C.IMeanLower C.IUpper C.IMeanLower C.IUpper C.I HOMA-IR2.142.002.282.372.212.542.562.382.743.442.903.97\<0.0001 Log (HOMA-IR)0.690.630.750.780.720.840.860.790.921.060.971.15\<0.0001TG/HDL-C^e^*N* = 341*N* = 277*N* = 220*N* = 143MeanLower C.IUpper C.IMeanLower C.IUpper C.IMeanLower C.IUpper C.IMeanLower C.IUpper C.I HOMA-IR2.232.032.442.282.162.412.642.452.833.613.104.13\<0.0001 Log (HOMA-IR)0.700.650.760.750.700.810.870.800.941.161.071.25\<0.0001non-HDL-C/HDL-C^f^*N* = 332*N* = 275*N* = 233*N* = 141MeanLower C.IUpper C.IMeanLower C.IUpper C.IMeanLower C.IUpper C.IMeanLower C.IUpper C.I HOMA-IR2.152.002.302.292.172.412.772.443.093.643.104.18\<0.0001 Log (HOMA-IR)0.690.630.750.760.710.810.890.820.961.161.061.26\<0.0001*p*-values were obtained via the SURVEYMEANS procedure*LDL-C* Low-density lipoprotein cholesterol, *HDL-C* High-density lipoprotein cholesterol, *TG* Triglyceride, *HOMA-IR* Homeostasis model assessment of insulin resistance, *C.I.* Confidence interval^a^1st quartile group (\<1.64000), 2nd quartile group (1.64000--2.15895), 3rd quartile group (2.15895--2.78788), 4th quartile group (≥2.78788)^b^1st quartile group (\<1.25581), 2nd quartile group (1.25581--2.04302), 3rd quartile group (2.04302--3.50000), 4th quartile group (≥3.50000)^c^1st quartile group (\<174), 2nd quartile group (174--223), 3rd quartile group (223--291), 4th quartile group (≥291)^d^1st quartile group (\<1.64000), 2nd quartile group (1.64000--2.15895), 3rd quartile group (2.15895--2.78788), 4th quartile group (≥2.78788)^e^1st quartile group (\<1.25581), 2nd quartile group (1.25581--2.04302), 3rd quartile group (2.04302--3.50000), 4th quartile group (≥3.50000)^f^1st quartile group (\<3.07042), 2nd quartile group (3.07042--4.28846), 3rd quartile group (4.28846--6.31818), 4th quartile group (≥6.31818)

Statistically significant differences were observed within each sex among all 3 sets of quartile groups (mean LDL-C/HDL-C, TG/HDL-C, and non-HDL-C/HDL-C ratios; *p*-values were obtained via the SURVEYMEANS procedure). In both sexes, HOMA-IR values tended to increase as the LDL-C/HDL-C, TG/HDL-C, and non-HDL-C/HDL-C ratios increased.

Multiple linear regression model of log transformed HOMA-IR values in men {#Sec11}
-------------------------------------------------------------------------

Table [3](#Tab3){ref-type="table"} lists the results of analytical evaluations of the associations of individual lipid measure ratios (LDL-C/HDL-C ratio, TG/HDL-C ratio and non-HDL-C/HDL-C ratio) with HOMA-IR according to a multiple linear regression test. In men, multiple linear regression analyses revealed that after adjusting for the confounding factors of age, BMI, and medical history of diabetes mellitus, a significant positive association was only observed with the LDL-C/HDL-C ratio (*p*-value = 0.0238, adjusted R^2^ = 0.3588, root mean square error \[MSE\] =0.3512).Table 3Results of the multiple linear regression model for log transformed HOMA-IRMenWomenEstimateStandard error*p*-valueAdjusted R^2^Root MSEEstimateStandard error*p*-valueAdjusted R^2^Root MSE*Model with LDL-C/HDL-C*0.35880.35120.23090.3776Age−0.00100.00120.3953−0.00270.00130.0451BMI0.04290.0086\<0.00010.02470.01000.0149Waist Circumference0.01010.00280.00070.00660.00390.0919Diabetes^a^0.39110.0621\<0.00010.35780.10140.0005LDL-C/HDL-C Ratio0.03830.01680.02380.10150.0242\<0.0001*Model with TG/HDL-C*0.36410.34970.23530.3766Age−0.00100.00130.4126−0.00250.00130.0529BMI0.04450.0083\<0.00010.02560.01010.010Waist Circumference0.00970.00290.00090.00650.00420.1206Diabetes^a^0.38680.0635\<0.00010.34150.09980.0008TG/HDL-C Ratio0.00860.00700.22220.04850.01240.0001*Model with non-HDL-C/HDL-C*0.36620.34910.24370.3745Age−0.00110.00130.3690−0.00300.00130.0224BMI0.04390.0084\<0.00010.02420.01000.0164Waist Circumference0.00960.00290.00090.00600.00410.1421Diabetes^a^0.38980.0632\<0.00010.33940.09690.0006Non-HDL-C/HDL-C Ratio0.00910.00690.19070.04480.0095\<0.0001*p-*values were evaluated using the SURVEYMEANS procedure (LDL-C/HDL-C, TG/HDL-C, and non-HDL-C/HDL-C ratios were treated as continuous values)*R* ^*2*^ Root-square, *Root MSE* Root mean squared error, *HOMA-IR* Homeostasis model assessment of insulin resistance, *LDL-C/HDL-C* Low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio, *TG/HDL-C* Triglyceride/high-density lipoprotein cholesterol ratio, *non-HDL-C/HDL-C* Non-high-density lipoprotein cholesterol (LDL-C + triglyceride)/HDL-C ratio, *BMI* Body mass index^a^Diabetes was defined as a medical history of diabetes mellitus

Multiple linear regression model of log transformed HOMA-IR values in women {#Sec12}
---------------------------------------------------------------------------

In women, multiple linear regression analyses showed that after adjusting for the confounding factors of age, BMI, and medical history of diabetes mellitus, significant positive associations were observed with the LDL-C/HDL-C ratio (*p*-value \<0.0001, adjusted R^2^ = 0.2309, root MSE = 0.3776), TG/HDL-C ratio (*p*-value = 0.0001, adjusted R^2^ = 0.2353, root MSE = 0.3766), and non-HDL-C/HDL-C ratio (*p*-value \< 0.0001, adjusted R^2^ = 0.2437, root MSE = 0.3745) (Table [3](#Tab3){ref-type="table"}).

Discussion {#Sec13}
==========

This study was performed to evaluate sex-based associations between lipid concentration ratios (e.g., LDL-C/HDL-C, TG/HDL-C, and non-HDL-C/HDL-C) and HOMA-IR values in order to determine the strongest predictor of IR in each sex. According to the results, only the LDL-C/HDL-C ratio was significantly and positively associated with HOMA-IR values in men. On the other hand, the LDL-C/HDL-C (*p*-value \< 0.0001, adjusted R^2^ = 0.2309, root MSE = 0.3776), TG/HDL-C (*p*-value = 0.0001, adjusted R^2^ = 0.2353, root MSE = 0.3766), and non-HDL-C/HDL-C ratios (*p*-value \< 0.0001, adjusted R^2^ = 0.2437, root MSE = 0.3745) were all significantly and positively associated with HOMA-IR values in women.

In most cases, patients with IR have hypertriglyceridemia and low HDL-C levels because insulin affects the metabolism of very low-density lipoprotein cholesterol (VLDL-C) and HDL-C \[[@CR19]\]. Systemically circulating insulin inhibits the secretion of VLDL-C and stimulates the activation of lipoprotein lipase (LPL). However, if IR occurs, more TG is synthesized in the liver, thus increasing apolipoprotein B levels via increased fat generation, increasing VLDL-C secretion, and decreasing the concentration and activity of LPL in peripheral tissues, especially adipose tissue. Ultimately, the decrease in HDL-C levels occurs as a secondary process following an increase in TG \[[@CR20]\].

Many previous studies have suggested various lipid ratios as simple and useful parameters for determining IR. For example, when TG levels and TG/HDL-C ratios were compared and analyzed in 50 Caucasian Americans, the areas under the receiver-operating characteristic curves (AUCs) were 0.763 and 0.770, respectively, suggesting that the TG/HDL-C ratio was a significant predictor of IR. However, the significance of this ratio was low among African-Americans \[[@CR11]\]. In another study in which the TG/HDL-C and total cholesterol/HDL-C ratios were compared in 2,014 patients, the TG/HDL-C ratio was reported to be an imperfect but statistically significant (AUC = 0.745, *p*-value \< 0.001) predictor of the risks of IR and coronary artery disease \[[@CR12]\]. According to a recent analysis of 1,393 Japanese subjects, the LDL-C/HDL-C ratio was found to be a significant predictor of IR among non-obese subjects (AUC = 0.74, *p*-value \< 0.001), with a cut-off value of 2.14 \[[@CR13]\]. Therefore, the best lipid profile ratio for predicting IR remains controversial.

We focused on sex-based differences to determine the most IR-predictive lipid profile ratios. One previous study suggested that women and men have significantly different lipid, apoprotein, and lipoprotein values (lower BMI, TG, and total cholesterol/HDL-C ratio values and higher HDL-C values in women vs. men) \[[@CR21]\]. Another study also suggested that women have higher apolipoproteinA-I production rates, compared with men \[[@CR22]\]. The results of the present study support these previously reported differences (Table [3](#Tab3){ref-type="table"}). In the present study, women had significantly lower BMI and TG values and significantly higher HDL-C values. Therefore, we performed a multiple regression analysis of each lipid profile ratio in each sex.

The present study has the following strengths. In this study, the best predictor of IR was examined in each sex, an investigation that has not been previously reported. Accordingly, only the LDL-C/HDL-C ratio was found to be significantly associated with HOMA-IR values in men, whereas a regression model revealed that the LDL-C/HDL-C, TG/HDL-C, non-HDL-C/HDL-C ratios were clinically significant in women. In addition, as only 6.91 % (132) of the subjects had a medical history of diabetes mellitus, the results of the present study can be fully applied to healthy adult Korean groups in clinical settings.

The limitations of this study are as follows. First, as this was a cross-sectional study based on data from KNHANES 2010, inaccurate information and recall errors might have been introduced through the interview methods and self-administered questionnaires. Second, as other risk factors of IR such as family history, medical history of gestational diabetes mellitus, or presence of an inflammatory reaction were not considered, these might have affected the outcomes. Finally, cut-off values for the lipid profile ratios found to be optimum predictors of IR could not be determined in this study; this issue will require further evaluation in an additional large-scale study in the future.

Conclusions {#Sec14}
===========

We suggest that the LDL-C/HDL-C ratio and the LDL-C/HDL-C, TG/HDL-C, and non-HDL-C/HDL-C ratios could be clinically significant predictors of IR in healthy adult men and women, respectively. However, additional large-scale studies will be required to evaluate the optimum cut-off values for the lipid profile ratios used to determine IR in each sex.
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